Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Spirituality and resilience among family caregivers of survivors of stroke: A scoping review.

Gibbs LAL, Anderson MI, Simpson GK, Jones KF.

NeuroRehabilitation. 2020 Feb 3. doi: 10.3233/NRE-192946. [Epub ahead of print]

PMID:
32039873
2.

Do spirituality, resilience and hope mediate outcomes among family caregivers after traumatic brain injury or spinal cord injury? A structural equation modelling approach.

Simpson GK, Anderson MI, Jones KF, Genders M, Gopinath B.

NeuroRehabilitation. 2020 Feb 3. doi: 10.3233/NRE-192945. [Epub ahead of print]

PMID:
32039872
3.

Rehabilitation health professionals' perceptions of spirituality and spiritual care: The results of an online survey.

Jones KF, Pryor J, Care-Unger C, Simpson GK.

NeuroRehabilitation. 2020 Feb 3. doi: 10.3233/NRE-192857. [Epub ahead of print]

PMID:
32039867
4.

Differential Inhibition of APOBEC3 DNA-Mutator Isozymes by Fluoro- and Non-Fluoro-Substituted 2'-Deoxyzebularine Embedded in Single-Stranded DNA.

Kvach MV, Barzak FM, Harjes S, Schares HAM, Kurup HM, Jones KF, Sutton L, Donahue J, D'Aquila RT, Jameson GB, Harki DA, Krause KL, Harjes E, Filichev VV.

Chembiochem. 2019 Oct 21. doi: 10.1002/cbic.201900505. [Epub ahead of print]

PMID:
31633265
5.

Assessing protein sequencing in human single hair shafts of decreasing lengths.

Jones KF, Carlson TL, Eckenrode BA, Donfack J.

Forensic Sci Int Genet. 2020 Jan;44:102145. doi: 10.1016/j.fsigen.2019.102145. Epub 2019 Sep 27.

PMID:
31590061
6.

Buprenorphine Use in Palliative Care.

Jones KF.

J Hosp Palliat Nurs. 2019 Dec;21(6):540-547. doi: 10.1097/NJH.0000000000000598.

PMID:
31568111
7.

A study of whether individual and dyadic relations between spirituality and resilience contribute to psychological adjustment among individuals with spinal cord injuries and their family members.

Jones KF, Simpson G, Briggs L, Dorsett P, Anderson M.

Clin Rehabil. 2019 Sep;33(9):1503-1514. doi: 10.1177/0269215519845034. Epub 2019 May 6.

PMID:
31056938
8.

A potent Lassa virus antiviral targets an arenavirus virulence determinant.

Madu IG, Files M, Gharaibeh DN, Moore AL, Jung KH, Gowen BB, Dai D, Jones KF, Tyavanagimatt SR, Burgeson JR, Korth MJ, Bedard KM, Iadonato SP, Amberg SM.

PLoS Pathog. 2018 Dec 21;14(12):e1007439. doi: 10.1371/journal.ppat.1007439. eCollection 2018 Dec.

9.

A study of the intrinsic variability and the effect of environmental conditions on the formation of a postmortem root band.

Damaso N, Jones KF, Carlson TL, Fleming J, Steadman DW, Jantz LM, Hauther K, Otterstatter LM, Donfack J.

Forensic Sci Int. 2018 Dec;293:63-69. doi: 10.1016/j.forsciint.2018.09.032. Epub 2018 Oct 25.

PMID:
30399603
10.

Spirituality and its relationship with positive adjustment following traumatic brain injury: a scoping review.

Jones KF, Pryor J, Care-Unger C, Simpson GK.

Brain Inj. 2018;32(13-14):1612-1622. doi: 10.1080/02699052.2018.1511066. Epub 2018 Sep 5.

PMID:
30182741
11.

Moving forward on the journey: Spirituality and family resilience after spinal cord injury.

Jones KF, Dorsett P, Simpson G, Briggs L.

Rehabil Psychol. 2018 Nov;63(4):521-531. doi: 10.1037/rep0000229. Epub 2018 Jul 19.

PMID:
30024204
12.

The role of spirituality in spinal cord injury (SCI) rehabilitation: exploring health professional perspectives.

Jones KF, Dorsett P, Briggs L, Simpson GK.

Spinal Cord Ser Cases. 2018 Jun 26;4:54. doi: 10.1038/s41394-018-0078-3. eCollection 2018.

13.

Social work-generated evidence in traumatic brain injury from 1975 to 2014: A systematic scoping review.

Mantell A, Simpson GK, Vungkhanching M, Jones KF, Strandberg T, Simonson P.

Health Soc Care Community. 2018 Jul;26(4):433-448. doi: 10.1111/hsc.12476. Epub 2017 Aug 9. Review.

PMID:
28795463
14.

Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection.

Amantana A, Chen Y, Tyavanagimatt SR, Jones KF, Jordan R, Chinsangaram J, Bolken TC, Leeds JM, Hruby DE.

PLoS One. 2013 Apr 18;8(4):e61514. doi: 10.1371/journal.pone.0061514. Print 2013.

15.

Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase.

Byrd CM, Grosenbach DW, Berhanu A, Dai D, Jones KF, Cardwell KB, Schneider C, Yang G, Tyavanagimatt S, Harver C, Wineinger KA, Page J, Stavale E, Stone MA, Fuller KP, Lovejoy C, Leeds JM, Hruby DE, Jordan R.

Antimicrob Agents Chemother. 2013 Apr;57(4):1902-12. doi: 10.1128/AAC.02251-12. Epub 2013 Feb 12.

16.

A novel inhibitor of dengue virus replication that targets the capsid protein.

Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E, Tyavanagimatt S, Stone MA, Bartenschlager R, Scaturro P, Hruby DE, Jordan R.

Antimicrob Agents Chemother. 2013 Jan;57(1):15-25. doi: 10.1128/AAC.01429-12. Epub 2012 Oct 15.

17.

Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers.

Chinsangaram J, Honeychurch KM, Tyavanagimatt SR, Leeds JM, Bolken TC, Jones KF, Jordan R, Marbury T, Ruckle J, Mee-Lee D, Ross E, Lichtenstein I, Pickens M, Corrado M, Clarke JM, Frimm AM, Hruby DE.

Antimicrob Agents Chemother. 2012 Sep;56(9):4900-5. doi: 10.1128/AAC.00904-12. Epub 2012 Jul 9.

18.

Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers.

Chinsangaram J, Honeychurch KM, Tyavanagimatt SR, Bolken TC, Jordan R, Jones KF, Marbury T, Lichtenstein I, Pickens M, Corrado M, Landis P, Clarke JM, Frimm AM, Hruby DE.

Antimicrob Agents Chemother. 2012 Jul;56(7):3582-6. doi: 10.1128/AAC.06090-11. Epub 2012 Apr 23.

19.

Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.

Chen Y, Amantana A, Tyavanagimatt SR, Zima D, Yan XS, Kasi G, Weeks M, Stone MA, Weimers WC, Samuel P, Tan Y, Jones KF, Lee DR, Kickner SS, Saville BM, Lauzon M, McIntyre A, Honeychurch KM, Jordan R, Hruby DE, Leeds JM.

PLoS One. 2011;6(8):e23237. doi: 10.1371/journal.pone.0023237. Epub 2011 Aug 15.

20.

Evaluation of Lassa antiviral compound ST-193 in a guinea pig model.

Cashman KA, Smith MA, Twenhafel NA, Larson RA, Jones KF, Allen RD 3rd, Dai D, Chinsangaram J, Bolken TC, Hruby DE, Amberg SM, Hensley LE, Guttieri MC.

Antiviral Res. 2011 Apr;90(1):70-9. doi: 10.1016/j.antiviral.2011.02.012. Epub 2011 Mar 1.

21.

Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.

Berhanu A, King DS, Mosier S, Jordan R, Jones KF, Hruby DE, Grosenbach DW.

Vaccine. 2010 Dec 16;29(2):289-303. doi: 10.1016/j.vaccine.2010.10.039. Epub 2010 Oct 29.

22.

Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects.

Jordan R, Chinsangaram J, Bolken TC, Tyavanagimatt SR, Tien D, Jones KF, Frimm A, Corrado ML, Pickens M, Landis P, Clarke J, Marbury TC, Hruby DE.

Antimicrob Agents Chemother. 2010 Jun;54(6):2560-6. doi: 10.1128/AAC.01689-09. Epub 2010 Apr 12.

23.

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice.

Grosenbach DW, Berhanu A, King DS, Mosier S, Jones KF, Jordan RA, Bolken TC, Hruby DE.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):838-43. doi: 10.1073/pnas.0912134107. Epub 2009 Dec 22.

24.

ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation.

Berhanu A, King DS, Mosier S, Jordan R, Jones KF, Hruby DE, Grosenbach DW.

Antimicrob Agents Chemother. 2009 Dec;53(12):4999-5009. doi: 10.1128/AAC.00678-09. Epub 2009 Sep 14.

25.

Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor.

Jordan R, Tien D, Bolken TC, Jones KF, Tyavanagimatt SR, Strasser J, Frimm A, Corrado ML, Strome PG, Hruby DE.

Antimicrob Agents Chemother. 2008 May;52(5):1721-7. doi: 10.1128/AAC.01303-07. Epub 2008 Mar 3.

26.

Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.

Grosenbach DW, Jordan R, King DS, Berhanu A, Warren TK, Kirkwood-Watts DL, Tyavanagimatt S, Tan Y, Wilson RL, Jones KF, Hruby DE.

Vaccine. 2008 Feb 13;26(7):933-46. doi: 10.1016/j.vaccine.2007.11.095. Epub 2007 Dec 26.

27.

Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.

Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.

J Virol. 2008 Apr;82(7):3517-29. doi: 10.1128/JVI.01854-07. Epub 2008 Jan 16.

28.
29.

Listeria monocytogenes 10403S HtrA is necessary for resistance to cellular stress and virulence.

Wilson RL, Brown LL, Kirkwood-Watts D, Warren TK, Lund SA, King DS, Jones KF, Hruby DE.

Infect Immun. 2006 Jan;74(1):765-8.

30.

Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.

Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, Bleam M, Hruby DE.

Antiviral Res. 2006 Feb;69(2):86-97. Epub 2005 Nov 28.

PMID:
16343651
32.
34.

What do physician recommendations of health plans mean?

Wholey DR, Christianson JB, Jones KF, Finch M; Physicians Evaluating Health Plans Research Team.

Am J Manag Care. 2003 Jun;9 Spec No 2:SP88-99.

35.

Statistical analysis of inappropriate results from current Hb screening methods for blood donors.

James V, Jones KF, Turner EM, Sokol RJ.

Transfusion. 2003 Mar;43(3):400-4.

PMID:
12675728
36.

Student questions Resolution 19.

Jones KF.

WMJ. 2002;101(4):4-5. No abstract available.

PMID:
12152515
37.

Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors.

Byrd CM, Bolken TC, Jones KF, Warren TK, Vella AT, McDonald J, King D, Blackwood Z, Hruby DE.

Vaccine. 2002 May 22;20(17-18):2197-205.

PMID:
12009273
38.

Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors.

Bolken TC, Franke CA, Jones KF, Bell RH, Swanson RM, King DS, Fischetti VA, Hruby DE.

Infect Immun. 2002 May;70(5):2487-91.

39.
40.

Inactivation of the srtA gene in Streptococcus gordonii inhibits cell wall anchoring of surface proteins and decreases in vitro and in vivo adhesion.

Bolken TC, Franke CA, Jones KF, Zeller GO, Jones CH, Dutton EK, Hruby DE.

Infect Immun. 2001 Jan;69(1):75-80.

42.
43.
44.
45.

Update in pediatric dentistry.

Jones KF, Berg JH, Coody D.

J Pediatr Health Care. 1994 Jul-Aug;8(4):160-7.

PMID:
8040797
46.

Fluoride supplementation. A survey of pediatricians and pediatric dentists.

Jones KF, Berg JH.

Am J Dis Child. 1992 Dec;146(12):1488-91.

PMID:
1456266
47.

Analgesic efficacy of bromfenac, ibuprofen, and aspirin in postoperative oral surgery pain.

Forbes JA, Beaver WT, Jones KF, Edquist IA, Gongloff CM, Smith WK, Smith FG, Schwartz MK.

Clin Pharmacol Ther. 1992 Mar;51(3):343-52.

PMID:
1544291
48.

Genetic diversity among the T-protein genes of group A streptococci.

Jones KF, Schneewind O, Koomey JM, Fischetti VA.

Mol Microbiol. 1991 Dec;5(12):2947-52.

PMID:
1809837
49.

Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain.

Forbes JA, Beaver WT, Jones KF, Kehm CJ, Smith WK, Gongloff CM, Zeleznock JR, Smith JW.

Clin Pharmacol Ther. 1991 Jun;49(6):674-84.

PMID:
2060256
50.

Supplemental Content

Loading ...
Support Center